These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9314961)

  • 1. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT.
    Platt JF; Francis IR; Ellis JH; Reige KA
    Radiology; 1997 Oct; 205(1):49-53. PubMed ID: 9314961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?
    Sheafor DH; Killius JS; Paulson EK; DeLong DM; Foti AM; Nelson RC
    Radiology; 2000 Mar; 214(3):875-80. PubMed ID: 10715061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
    Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
    AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases.
    Platt JF; Francis IR; Ellis JH; Reige KA
    J Comput Assist Tomogr; 1997; 21(3):348-54. PubMed ID: 9135639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
    Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
    Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer: value of dual-phase helical CT in assessing resectability.
    Diehl SJ; Lehmann KJ; Sadick M; Lachmann R; Georgi M
    Radiology; 1998 Feb; 206(2):373-8. PubMed ID: 9457188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning.
    Silverman PM; O'Malley J; Tefft MC; Cooper C; Zeman RK
    AJR Am J Roentgenol; 1995 Mar; 164(3):619-23. PubMed ID: 7863882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
    Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
    Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases.
    Park JH; Nazarian LN; Halpern EJ; Feld RI; Lev-Toaff AS; Parker L; Wechsler RJ
    Acad Radiol; 2001 Aug; 8(8):698-704. PubMed ID: 11508748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?
    Frederick MG; McElaney BL; Singer A; Park KS; Paulson EK; McGee SG; Nelson RC
    AJR Am J Roentgenol; 1996 Jun; 166(6):1305-10. PubMed ID: 8633437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.
    Sheafor DH; Frederick MG; Paulson EK; Keogan MT; DeLong DM; Nelson RC
    AJR Am J Roentgenol; 1999 Apr; 172(4):961-8. PubMed ID: 10587129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?
    Oliver JH; Baron RL; Federle MP; Jones BC; Sheng R
    Radiology; 1997 Dec; 205(3):709-15. PubMed ID: 9393525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients.
    Chambers TP; Baron RL; Lush RM
    Radiology; 1994 Nov; 193(2):513-7. PubMed ID: 7972770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
    Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
    AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
    Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols.
    Leggett DA; Kelley BB; Bunce IH; Miles KA
    Radiology; 1997 Dec; 205(3):716-20. PubMed ID: 9393526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.